SAR439794
Total Payments
$849,904
Transactions
513
Doctors
5
Companies
2
Payment Trends by Year
| Year | Amount | Transactions | Doctors |
|---|---|---|---|
| 2019 | $337,403 | 94 | 0 |
| 2018 | $315,476 | 417 | 5 |
| 2017 | $197,024 | 2 | 0 |
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Unspecified | $849,468 | 498 | 99.9% |
| Food and Beverage | $435.30 | 15 | 0.1% |
Payments by Type
Research
$849,468
498 transactions
General
$435.30
15 transactions
Research Studies & Clinical Trials
| Study Name | Sponsor | Amount | Doctors |
|---|---|---|---|
| A Randomized, Multicenter, 3-arm, Double-blind, Placebo-controlled Study to Assess the Safety, Tolerability and Pharmacodynamics of Repeated Sublingual Daily Administration of SAR439794 in Peanut Alle | SANOFI US SERVICES INC. | $544,994 | 0 |
| Tolerance Single Dose-SL-Assessment of local tolerability of sublingual GLA | SANOFI US SERVICES INC. | $210,008 | 0 |
| A Randomized, Multicenter, 3-arm, Double-blind, Placebo-controlled Study to Assess the Safety, Tolerability and Pharmacodynamics of Repeated Sublingual Daily Administration of SAR439794 in Peanut Allergic Adult Patients | SANOFI US SERVICES INC. | $81,210 | 0 |
| A randomized multicenter 3-arm double blind placebo controlled study to assess the safety tolerability and pharmacodynamics of repeated sublingual daily adminstration of SAR439794 in peanut allergic a | SANOFI US SERVICES INC. | $13,256 | 0 |
Top Doctors Receiving Payments for SAR439794
| Doctor | Specialty | Location | Total | Records |
|---|---|---|---|---|
| Unknown | — | Saint Paul, MN | $849,468 | 498 |
| , M.D | Allergy & Immunology | Chapel Hill, NC | $87.06 | 3 |
| , M.D | Allergy | Baltimore, MD | $87.06 | 3 |
| , M.D | Allergy & Immunology | San Diego, CA | $87.06 | 3 |
| , MD | Pediatrics | Philadelphia, PA | $87.06 | 3 |
| , MD, MBA | Pediatrics | Ann Arbor, MI | $87.06 | 3 |
Ad
Manufacturing Companies
- SANOFI US SERVICES INC. $849,468
- SANOFI-AVENTIS U.S. LLC $435.30
Product Information
- Type Drug
- Total Payments $849,904
- Total Doctors 5
- Transactions 513
About SAR439794
SAR439794 is a drug associated with $849,904 in payments to 5 healthcare providers, recorded across 513 transactions in the CMS Open Payments database. The primary manufacturer is SANOFI US SERVICES INC..
Payment data is available from 2017 to 2019. In 2019, $337,403 was paid across 94 transactions to 0 doctors.
The most common payment nature for SAR439794 is "Unspecified" ($849,468, 99.9% of total).
SAR439794 is associated with 4 research studies, including "A Randomized, Multicenter, 3-arm, Double-blind, Placebo-controlled Study to Assess the Safety, Tolerability and Pharmacodynamics of Repeated Sublingual Daily Administration of SAR439794 in Peanut Alle" ($544,994).